From: Epithelial-myoepithelial carcinoma: a population-based survival analysis
Total | 468 | 100% |
---|---|---|
Age, years | ||
10–14 years | 2 | 0.4% |
15–19 years | 2 | 0.4% |
20–24 years | 2 | 0.4% |
25–29 years | 8 | 1.7% |
30–34 years | 7 | 1.5% |
35–39 years | 10 | 2.1% |
40–44 years | 15 | 3.2% |
45–49 years | 30 | 6.4% |
50–54 years | 50 | 10.7% |
55–59 years | 55 | 11.8% |
60–64 years | 44 | 9.4% |
65–69 years | 66 | 14.1% |
70–74 years | 60 | 12.8% |
75–79 years | 45 | 9.6% |
80–84 years | 35 | 7.5% |
85+ years | 37 | 7.9% |
Sex | ||
Female | 291 | 62.2% |
Male | 177 | 37.8% |
Race | ||
White | 365 | 78.0% |
Black | 52 | 11.1% |
Other (American Indian/AK Native, Asian/Pacific Islander) | 46 | 9.8% |